DUBLIN, March 8, 2017 /PRNewswire/ -- Perrigo Company plc
(NYSE; TASE: PRGO) today announced the first-to-market launch of
the over-the-counter ("OTC") store brand equivalent to Women's
Rogaine® 5% minoxidil foam (minoxidil topical aerosol,
5% foam). First shipments of this new store foam have already been
initiated. This product is packaged and marketed as a store brand
or retailer 'own label' brand and provides consumers a
high-quality, value alternative to the Women's Rogaine®
5% minoxidil foam product.
Women's Rogaine® 5% minoxidil foam (minoxidil topical
aerosol, 5% foam) is indicated to regrow hair on top of the scalp.
Annual sales for the 12 months ending February 2017 were approximately $20 million.
Perrigo's CEO John T. Hendrickson
stated, "This final approval and OTC launch is another example of
introducing new store brand products that are equivalent to the
national brand while providing consumers with a lower cost
alternative in the marketplace. As always, Perrigo is committed to
making quality healthcare more affordable for our customers and
consumers around the world."
About Perrigo
Perrigo Company plc, a leading global over-the-counter ("OTC")
consumer goods company, offers patients and customers high quality
products at affordable prices. From its beginnings in 1887 as a
packager of generic home remedies, Perrigo, headquartered in
Ireland, has grown to become the
world's largest manufacturer of OTC healthcare products and
supplier of infant formulas for the store brand market. The Company
is also a leading provider of generic extended topical prescription
products in the U.S. and currently receives royalties from sales of
the multiple sclerosis drug Tysabri®. Perrigo provides "Quality
Affordable Healthcare Products®" across a wide variety of product
categories and geographies primarily in North America, Europe and Australia, as well as in other markets,
including Israel, China and Latin
America. Visit Perrigo online at
(http://www.perrigo.com).
Forward-Looking Statements
Certain statements in this press release are "forward-looking
statements." These statements relate to future events or the
Company's future financial performance and involve known and
unknown risks, uncertainties and other factors that may cause the
actual results, levels of activity, performance or achievements of
the Company or its industry to be materially different from those
expressed or implied by any forward-looking statements. In some
cases, forward-looking statements can be identified by terminology
such as "may," "will," "could," "would," "should," "expect,"
"plan," "anticipate," "intend," "believe," "estimate," "predict,"
"potential" or the negative of those terms or other comparable
terminology. The Company has based these forward-looking statements
on its current expectations, assumptions, estimates and
projections. While the Company believes these expectations,
assumptions, estimates and projections are reasonable, such
forward-looking statements are only predictions and involve known
and unknown risks and uncertainties, many of which are beyond the
Company's control, including the time, effort and expense to
complete its 2016 Form 10-K, future impairment charges, the ability
to achieve its guidance, the ability to execute and achieve the
desired benefits of announced initiatives, and the timing, amount
and cost of share repurchases. In addition, there can be no
assurance that the Company will be able to file its 2016 Form 10-K
within the fifteen calendar day extension provided by Rule 12b-25,
or that the Company may not identify one or more material
weaknesses in its internal control over financial reporting, need
to restate its financial statements, conclude that investors should
no longer rely upon previously issued financial statements or
maintain compliance with the NYSE continued listing rules.
Furthermore, if the Company and/or its subsidiaries are required to
restate their financial statements, it and/or its subsidiaries may
incur additional tax liabilities in respect of 2016 and prior years
or may be found to have breached certain provisions of Irish
company legislation in respect of prior financial statements and if
so, may incur additional expenses and penalties. These and other
important factors, including those discussed under "Risk Factors"
in the Company's Form 10-KT for the six-month period ended
December 31, 2015, as well as the
Company's subsequent filings with the United States Securities and
Exchange Commission, may cause actual results, performance or
achievements to differ materially from those expressed or implied
by these forward-looking statements. The forward-looking statements
in this press release are made only as of the date hereof, and
unless otherwise required by applicable securities laws, the
Company disclaims any intention or obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/perrigo-announces-first-to-market-launch-of-the-otc-store-brand-equivalent-to-womens-rogaine-foam-300420228.html
SOURCE Perrigo Company plc